en_GB EN
en_GB EN es_ES ES
close
Contact

ABRA INVEST advises HEMOSOLVE on its strategic development


,
Integral service around a transaction
BY : Diego Gutiérrez | March Fri, 2013

ABRA INVEST has collaborated with HEMOSOLVE (exploitation of "sclerosing microfoam" for the treatment of haemorrhoids) through the design of a plan to develop its own clinics and agreements with other prestigious institutions.

History of microfoam sclerosants

In 1993 the Cabrera family invented the sclerosing microfoam. Since then it has been used to treat varicose veins effectively in more than 25,000 patients. As well as being treated in Cabrera's own 5 clinics, the treatment is used under licence by prestigious institutions such as the Clínica Universitaria de Navarra and Sanitas hospitals. Following the success of the microfoam treatment for varicose veins, the inventors have developed microfoam for haemorrhoids.

KEY POINTS:

1. Large size of affected population:

Symptomatic haemorrhoids affect at least 50% of the population at some point in their lives, with around 5% of the population suffering from them at any one time.
2. Advantages over surgery and others:
  • Outpatient treatment: no need for anaesthesia or surgery.
  • No specific post-treatment care and the patient can continue with normal life.
  • HEMOSOLVE can cure any type of haemorrhoid. Surgery only for the most acute ones.
  • Painless and easily repeatable procedure: The discomfort is similar to a blood draw.

3. Advantageous competitive position:

  • The technology is patented and IIDF has authorisation for use in Spain.
  • The treatment has been tested in more than 150 patients during 2011 and 2012 demonstrating its efficacy. The Granada Clinic is active.
  • Agreements with other institutions underway: agreement with Clínicas Cabrera to offer the treatment, agreement with Médico Digestivo to open a clinic in Madrid, etc.

The team composed of technical staff and professionals with business experience in the healthcare world is well prepared to develop the established business plan.

Diego Gutiérrez Zarza

Baker Tilly GDA
The M&A Professionals

Meet our services

CONTACT US

MEET
OUR
METODOLOGY

Do you want to be up to date?

SUSCRIBE OUR NEWSLETTER

Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?

M&A NEWS
INDUSTRIAL REPORTS
 Baker Tilly advises Coocrea on its sale to Grupo Castilla
M&A advisor rankings
 Webinar "Tech M&A Update" Abril 2024 - modelo de inversión Buy&Build
Eventos
 Jornada Formación: Impulsando el valor de las PYMEs tecnológicas
Eventos
 Oreka IT integrates the Catalan company and SAP partner Intarex
M&A advisor rankings
 Report about Industrial Technology 2024
AdTech, Advertising, AgTech, Analisis de Datos, Analytics
Enterprise Software 2024 Report
AdTech, Advertising, AgTech, Analisis de Datos, Analytics
2024 Information Technology Industry Report
AdTech, Advertising, AgTech, Analisis de Datos, Analytics
2024 Advertising Industry Report
AdTech, Advertising, AgTech, Analisis de Datos, Analytics
crossmenu